All Stories

  1. Clinical and laboratory manifestations and outcomes of human parvovirus B19 infections in sickle cell anemia with emphasis on the impact of hydroxyurea
  2. Rapid withdrawal of voxelotor can precipitate sickle cell disease related crisis
  3. A Systematic Review of Large Language Models in Medical Specialties: Applications, Challenges and Future Directions
  4. Immune reconstitution and survival, following hematopoietic stem cell transplantation in Omani patients with inborn errors of immunity
  5. Current Status and Management of Chronic Myeloid Leukemia in the Gulf Region: Survey Results and Expert Opinion
  6. The role of preoperative transfusion in sickle cell disease, a systematic review and meta-analysis
  7. CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA
  8. Multi-center study on mortality in children, and adults with sickle cell anemia-risk factors and causes of death
  9. Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry
  10. Appropriate Antiviral Therapy Can Prevent Hepatitis B Reactivation & Progression in Chronic Myeloid Leukemia on Therapy with Tyrosine Kinase Inhibitors
  11. Thrombopoietin-receptor agonists for adult patients with immune thrombocytopenia: a narrative review and an approach for managing patients fasting intermittently
  12. Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs
  13. Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East
  14. Artificial intelligence in sickle disease
  15. Influence of Voxelotor–hemoglobin complexes in the estimation of hemoglobin S levels by the current standard of care laboratory evaluation techniques
  16. The Role of Preoperative Transfusion in Sickle Cell Disease, a Systematic Review and Meta-Analysis
  17. ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS.
  18. Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells
  19. Outcome of pregnancy in sickle cell anemia patients with COVID-19 infection
  20. Clinicopathological Profile of Paroxysmal Nocturnal Hemoglobinuria among Omani Patients: A Case Series
  21. The Challenges in Diagnosis and Management of Acquired Thrombotic Thrombocytopenic Purpura: Consensus Report from Three Gulf Countries
  22. Human macrophages and monocyte-derived dendritic cells stimulate the proliferation of endothelial cells through midkine production
  23. Transplant Associated Graft versus Host Disease
  24. Predicting risk factors for thromboembolic complications in patients with sickle cell anaemia – lessons learned for prophylaxis
  25. A reanalysis of pain crises data from the pivotal l-glutamine in sickle cell disease trial
  26. Iron Overload in Patients With Heavily Transfused Sickle Cell Disease—Correlation of Serum Ferritin With Cardiac T2* MRI (CMRTools), Liver T2* MRI, and R2-MRI (Ferriscan®)
  27. Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease
  28. Nutritional and Hematological Status of Sudanese Women of Childbearing Age with Steady-state Sickle Cell Anemia
  29. Impact of COVID-19 on vasooclusive crisis in patients with sickle cell anaemia
  30. Clinical and laboratory features of Hemoglobin La Desirade variant in association with sickle cell and alpha thalassemia genes
  31. Respiratory Viral Infections in Sickle Cell Anemia: Special Emphasis on H1N1 Co-infection
  32. Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study
  33. A A Multicentre ICET-A Study of Confirmed SARS-CoV-2 Infection in Patients with Hemoglobinopathies: Preliminary Data from 10 Countries
  34. Efficiency of day 4 compared to day 6 stem cell mobilization in allogeneic stem cell donors
  35. Hematopoietic stem cell transplantation for patients with sickle cell disease in the Eastern Mediterranean
  36. Unique aspects of Graft-versus-host-disease management in the Eastern Mediterranean region: Report from the Eastern Mediterranean blood and marrow transplantation group: Special report
  37. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations
  38. Predictors of impending acute chest syndrome in patients with sickle cell anaemia
  39. Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients
  40. Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations
  41. PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN
  42. Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group
  43. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
  44. THE USE OF HPLC AS A TOOL FOR NEONATAL CORD BLOOD SCREENING OF HAEMOGLOBINOPATHY - A VALIDATION STUDY
  45. Can Gestational Anemia be Alleviated with Increased Awareness of its Causes and Management Strategies? Implications for Health Care Services
  46. Stability of fetal hemoglobin levels in patients receiving metformin therapy
  47. A novel p.Pro353His SERPINC1 mutation in the thrombin-binding region affecting stability of Antithrombin molecule in an extended Omani family
  48. First Cytogenetic Profile of Omani Patients with de novo Myelodysplastic Syndromes: Comparison with data from Asia, Africa, Europe and North and South America
  49. Impact of Educational Activities in Reducing Pre-Analytical Laboratory Errors: A quality initiative
  50. Haemoglobin Fontainebleau (HBA2: c. 64G>C) in Oman: molecular and haematological characteristics and interaction with various haemoglobinopathies
  51. Therapeutic drug monitoring-guided dosing of busulfan differs from weight-based dosing in hematopoietic stem cell transplant patients
  52. INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.
  53. Regulatory B Cells Are Functionally Impaired in Patients Having Hemophilia A With Inhibitors
  54. Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-cell Acute Lymphoblastic Leukemia
  55. ALLOIMMUNIZATION IN PATIENTS WITH SICKLE CELL DISEASE AND THALASSAEMIA: EXPERIENCE OF SINGLE CENTRE FROM OMAN
  56. Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures
  57. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group
  58. First Implementation of Transfusion Consent Policy in Oman: Audit of compliance from a tertiary care university hospital
  59. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011–2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT)
  60. Accuracy of Platelet Counting by Optical and Impedance Methods in Patients with Thrombocytopaenia and Microcytosis
  61. Mode of delivery and risk of intracranial haemorrhage in newborns with severe haemophilia A: a multicentre study in Gulf region
  62. Duplication 1q as primary and 3q in t(3;13) as secondary aberration in Fanconi anemia: Implications and literature review
  63. SERUM TOTAL BILIRUBIN, NOT CHOLELITHIASIS, IS INFLUENCED BY UGT1A1 POLYMORPHISM, ALPHA THALASSEMIA AND S GENOTYPE: FIRST REPORT ON COMPARISON BETWEEN ARAB-INDIAN AND AFRICAN S GENES
  64. Aetiological profile of women presenting with premature ovarian failure to a single tertiary care center in Oman
  65. Biclonal Gammopathy in Chronic Lymphocytic Leukemia: Case Report and Review of the Literature
  66. Rituximab Leads to Long Remissions in Patients with Chronic Immune Thrombocytopenia
  67. Safety of stem cell mobilization in donors with sickle cell trait
  68. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies
  69. The pneumatic tube system does not affect complete blood count results; a validation study at a tertiary care hospital
  70. Epidemiology of chemotherapy-induced neutropenia at a tertiary university hospital in Oman
  71. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature
  72. A stepwise α-thalassemia screening strategy in high-prevalence areas
  73. Genital Ulcer Development in Patients with Acute Promyelocytic Leukaemia Treated with All-Trans Retinoic Acid: A Case Series
  74. Transcranial Doppler Ultrasonography in Sickle Cell Disease
  75. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus
  76. Idiopathic thrombocytopenic purpura and hypokalaemic dRTA with compensated haemolysis and striking acanthocytosis in a band 3 (SLC4A1/AE1) A858D homozygote
  77. Coexistence of sickle cell disease and severe congenital neutropenia: first impressions can be deceiving
  78. Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients
  79. Complications of PORT-A-CATH® in patients with sickle cell disease
  80. dRTA and hemolytic anemia: first detailed description of SLC4A1 A858D mutation in homozygous state
  81. The β-globin promoter −71 C>T mutation is a β+ thalassemic allele
  82. Trends of Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region, 1984-2007
  83. Acute massive splenic infarction with complete liquefaction of the spleen in sickle cell disease
  84. Severity ranking of non-deletional alpha thalassemic alleles: insights from an Omani family study
  85. Sub-optimal serum gentamicin concentrations in sickle cell disease patients utilizing the Hartford protocol
  86. Complete recovery following sudden sensorineural hearing loss in a patient with sickle cell disease
  87. Hb Sheffield [β58(E2)Pro→His] in Oman: Potential Pitfall in Genetic Counseling
  88. Sensorineural hearing loss in sickle cell disease-A prospective study from Oman
  89. Clinical and laboratory characteristics of patients with sickle-cell and autoimmune/connective tissue diseases
  90. Predictive Value of Neutrophil to Lymphocyte Ratio in Outcomes of Patients with Acute Coronary Syndrome
  91. Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab
  92. Review: Management of Painful Vaso-Occlusive Crisis of Sickle-Cell Anemia: Consensus Opinion
  93. Forecasting Hemoglobinopathy Burden Through Neonatal Screening in Omani Neonates
  94. Isochromosome 9q as a sole anomaly in an Omani boy with acute lymphoblastic leukaemia
  95. Splenectomy for haematological disorders: A single center study in 150 patients from Oman
  96. Orbital Infarction in Sickle Cell Disease
  97. Hematopoietic stem cell transplantation in Oman
  98. Arterial and Venous Thrombotic Complications with Thalidomide in Multiple Myeloma
  99. Complex t(8;13;21)(q22;q14;q22)–A Novel Variant of t(8;21) in a Patient with Acute Myeloid Leukemia (AML–M2)
  100. Familial lymphoma in an Omani kindred with identical class II HLA type
  101. Biphenotypic leukemia with interstitial del(9)(q22q32) as a sole abnormality
  102. Trisomy 21 as a Sole Acquired Abnormality in an Adult Omani Patient with CD7- and CD9-Positive Acute Myeloid Leukemia
  103. Cytogenetic, morphological, and immunophenotypic patterns in Omani patients with de novo acute myeloid leukemia
  104. Sickle cell?haemoglobin E (HbSE) compound heterozygosity: a clinical and haematological study
  105. Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma
  106. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease
  107. Recovery of normal autologous myelopoiesis after graft rejection following allogeneic bone marrow transplant for agnogenic myeloid metaplasia
  108. Hereditary thrombophilia in ethnic omani patients
  109. Successful outcome with anagrelide in pregnancy
  110. Imatinib in pregnancy
  111. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis
  112. Cytokine profile of sickle cell disease in Oman
  113. Cytokines in Sickle Cell Disease
  114. Erythroid hypoplasia associated with leptospirosis
  115. Orbital involvement in sickle cell disease: A report of five cases and review literature